Ameloblastoma, is the most common, clinically significant odontogenic tumor. It is slow growing, locally invasive and has high rates of recurrence after treatment.
The ameloblastoma represents from 10 to 11 % of all odontogenic
tumors, being locally invasive, with variables expression and behavior.
Ameloblastoma may be asymptomatic in the early stages but later gradually increases in size causing facial asymmetry, loosening of teeth and very rarely pain.
The synonymy to designate this tumor has been multiple; for example, they have employee terms such as: basiloma, adamantinoma, adamantinoblastoma, epithelial odontoma, adamantinum cystadenoma, epithelial adamantinum and germ remains carcinoma.
🔘 DENTAL TRAINING: ORAL MEDICINE videos including FREE Webinars, Conferences and Clinical Cases to share
► ORAL MEDICINE: The 10 most viewed videos of 2020
They occur mainly between the fourth and fifth decades of life, except for the variety unicystic diagnosed between 20 and 30 years, is rare in children and the elderly.
Although some cases have been reported in the literature, no significant differences based on sex and race, although some authors are more related to the male and have suggested an increase in the incidence of ameloblastomas in East Africa.
It is not exclusive to the human race, cases having been described in sheep, monkeys, dogs, cats and rats.